Love/hate relationships of Achromobacter species and human macrophages
无色杆菌属与人类巨噬细胞的爱/恨关系
基本信息
- 批准号:BB/Y00440X/1
- 负责人:
- 金额:$ 68.59万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2024
- 资助国家:英国
- 起止时间:2024 至 无数据
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The success of pathogenic microbes depends on their ability to overcome immune barriers in the host including survival in host cells designed to kill pathogens (e.g., macrophages), which gobbled up microbes and trap them in membrane-bound vacuoles known as phagosomes. Engulfed pathogenic microbes, however, can disarm macrophages and counteract immune defenses by deploying proteins called effectors. When infections occur in healthy people, pathogens also elicit inflammatory responses that help the host to clear the infection. In contrast, susceptible people, such as those with cystic fibrosis, immunosuppressive therapies, diabetes, elderly, or undergoing major surgery, cannot readily overcome pathogens. Moreover, susceptible people can be infected by opportunistic bacteria that rarely cause infection in healthy people and often display high-level multidrug antibiotic resistance, which makes treatment more difficult. For example, my research group has discovered that cystic fibrosis (CF) gene-defective macrophages cannot destroy engulfed bacteria and play a central role in maintaining the chronic inflammation state associated with infections by opportunistic bacteria. The interplay between the host and the pathogen in these cases whereby the host is permissive to infection is not well understood, and emerging opportunistic pathogens, in general, are not well established as infection models. We think that intracellular pathogens engulfed by macrophages, combined with host underlying defects (e.g., CF mutations), induce a highly proinflammatory state that becomes deleterious to susceptible people with CF. To explore this idea, we first need to establish a relevant model system; we propose to use the emerging bacterium Achromobacter as a novel opportunistic pathogen and to compare Achromobacter's survival mechanisms in normal and CF-defective human macrophages, as non-susceptible and susceptible host cell models, respectively.Achromobacter bacteria are increasingly becoming the dominant microbes recovered from people with cystic fibrosis (PWCF) including those with end-stage lung disease. Very little is known on the pathogenesis of Achromobacter sp. However, we have recently discovered that Achromobacter bacteria isolated from PWCF can survive and divide intracellularly in human macrophages, ultimately destroying these cells by stimulating heightened inflammation. For this, we have also found that Achromobacter deploys bacterial toxins in the host cells and represses anti-inflammatory responses. In this research proposal we aim to define: (i) the bacterial properties associated with intracellular survival, and (ii) the macrophage cellular responses upon infection by comparing macrophages from healthy and CF people. We anticipate these studies will allow us to identify new ways to treat the infection in these people that may be applicable to other situations where the host is more susceptible due to diseases or medical treatments.
致病性微生物的成功取决于其克服宿主中免疫屏障的能力,包括旨在杀死病原体(例如巨噬细胞)的宿主细胞中的存活,这些宿主细胞(例如巨噬细胞)吞噬了微生物并将其捕获在被称为吞噬体的膜结合的液泡中。但是,吞没的致病微生物可以通过部署称为效应子的蛋白质来解除巨噬细胞和抵抗免疫防御的措施。当健康人中感染时,病原体还会引起炎症反应,帮助宿主清除感染。相比之下,易感人物,例如患有囊性纤维化,免疫抑制疗法,糖尿病,老年人或接受重大手术的人,无法轻易克服病原体。此外,易感人物可能会受到机会性细菌的感染,这些细菌很少引起健康人的感染,并且经常表现出高级多药抗生素耐药性,从而使治疗更加困难。例如,我的研究小组发现,囊性纤维化(CF)基因缺陷巨噬细胞不能破坏被吞噬的细菌,并且在维持与机会性细菌相关的慢性炎症状态方面起着核心作用。在这种情况下,宿主与病原体之间的相互作用允许宿主感染尚未得到充分了解,并且通常将新兴的机会性病原体确定为感染模型。我们认为,巨噬细胞吞没的细胞内病原体与宿主的潜在缺陷(例如CF突变)相结合,诱导了一种高度促进的疾病,该状态变得有害于易感CF的人。为了探索这个想法,我们首先需要建立相关的模型系统。我们建议将新兴细菌作为一种新型的机会性病原体,并将Achromobacter的生存机制比较正常和CF缺陷的人类巨噬细胞中的生存机制,分别是不易易感性和易感性宿主细胞模型,因为近卵细菌逐渐从cy fibres中恢复了cyStick,cy fibrise(Pwc cyst ics cyst ics)都在cy夫人中恢复过来。关于Achromobacter sp的发病机理,知之甚少。但是,我们最近发现,从pwcf中分离出来的细菌可以在人类巨噬细胞中生存和细胞内分裂,最终通过刺激增强的炎症来破坏这些细胞。为此,我们还发现,阿克罗莫杆菌在宿主细胞中部署细菌毒素并抑制抗炎反应。在这项研究建议中,我们旨在定义:(i)与细胞内存活相关的细菌特性,以及(ii)通过比较健康和CF人的巨噬细胞感染后巨噬细胞反应。我们预计这些研究将使我们能够确定这些人的感染方法,这些方法可能适用于其他情况,因为宿主由于疾病或药物治疗而更容易受到影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Miguel Valvano其他文献
Miguel Valvano的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Miguel Valvano', 18)}}的其他基金
Discovery Projects - Grant ID: DP210100362
发现项目 - 拨款 ID:DP210100362
- 批准号:
ARC : DP210100362 - 财政年份:2021
- 资助金额:
$ 68.59万 - 项目类别:
Discovery Projects
A conserved protein O-glycosylation pathway in the Burkholderia genus essential for bacterial fitness and antigenicity in humans
伯克霍尔德氏菌属中保守的蛋白质 O-糖基化途径对于人类细菌适应性和抗原性至关重要
- 批准号:
BB/T005807/1 - 财政年份:2020
- 资助金额:
$ 68.59万 - 项目类别:
Research Grant
Bacterial lipocalins: Novel role in bacterial protection against antibiotic-induced membrane lipid peroxidation
细菌脂质运载蛋白:在防止抗生素诱导的膜脂过氧化的细菌保护中的新作用
- 批准号:
BB/S006281/1 - 财政年份:2019
- 资助金额:
$ 68.59万 - 项目类别:
Research Grant
Burkholderia species in sugarcane: the relationship among antifungal production, intrinsic antimicrobial resistance, and pest biocontrol
甘蔗中的伯克霍尔德氏菌:抗真菌生产、内在抗菌素耐药性和害虫生物防治之间的关系
- 批准号:
BB/R022607/1 - 财政年份:2018
- 资助金额:
$ 68.59万 - 项目类别:
Research Grant
A novel family of type VI-secreted toxins affecting Rho GTPases, actin dynamics and inflammation
影响 Rho GTP 酶、肌动蛋白动力学和炎症的 VI 型分泌毒素的新家族
- 批准号:
MR/P022480/1 - 财政年份:2017
- 资助金额:
$ 68.59万 - 项目类别:
Research Grant
相似海外基金
CRII: SaTC: Towards Understanding and Defending Against New Waves of Online Hate
CRII:SaTC:理解和防御新一波的网络仇恨
- 批准号:
2245983 - 财政年份:2023
- 资助金额:
$ 68.59万 - 项目类别:
Standard Grant
Linking Social-Behavior Contextual Factors and Allostatic Load to Chronic Diseases in Diverse Asian Americans: A Socioecological Approach to Advancing Precision Medicine and Health Equity
将社会行为背景因素和稳态负荷与不同亚裔美国人的慢性病联系起来:推进精准医疗和健康公平的社会生态学方法
- 批准号:
10799170 - 财政年份:2023
- 资助金额:
$ 68.59万 - 项目类别:
The Socioecology of Sexual Minority Stigma: Data Harmonization to Address Confounding Bias and Investigate Cross-Level MentalHealth Effects
性少数耻辱的社会生态学:数据协调以解决混杂偏见并调查跨层面的心理健康影响
- 批准号:
10728261 - 财政年份:2023
- 资助金额:
$ 68.59万 - 项目类别:
Language Identity and Mental Health Disparities among Multilingual 1.5 Generation Asian/Asian American Immigrant Young Adults: A Mixed Methods Study
多语言 1.5 代亚裔/亚裔美国移民年轻人的语言认同和心理健康差异:混合方法研究
- 批准号:
10715803 - 财政年份:2023
- 资助金额:
$ 68.59万 - 项目类别:
Asian Americans & Racism: Individual and Structural Experiences (ARISE)
亚裔美国人
- 批准号:
10900989 - 财政年份:2023
- 资助金额:
$ 68.59万 - 项目类别: